PL3528825T3 - Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych - Google Patents

Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych

Info

Publication number
PL3528825T3
PL3528825T3 PL17835861T PL17835861T PL3528825T3 PL 3528825 T3 PL3528825 T3 PL 3528825T3 PL 17835861 T PL17835861 T PL 17835861T PL 17835861 T PL17835861 T PL 17835861T PL 3528825 T3 PL3528825 T3 PL 3528825T3
Authority
PL
Poland
Prior art keywords
compositions
changing
composition
methods
bacterial strains
Prior art date
Application number
PL17835861T
Other languages
English (en)
Inventor
Bernhard PÄTZOLD
Marc GÜELL
Original Assignee
S-Biomedic Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S-Biomedic Nv filed Critical S-Biomedic Nv
Publication of PL3528825T3 publication Critical patent/PL3528825T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL17835861T 2016-10-19 2017-10-19 Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych PL3528825T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662410329P 2016-10-19 2016-10-19
US201762536761P 2017-07-25 2017-07-25
EP17835861.0A EP3528825B1 (en) 2016-10-19 2017-10-19 Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
PCT/IB2017/001481 WO2018073651A1 (en) 2016-10-19 2017-10-19 Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains

Publications (1)

Publication Number Publication Date
PL3528825T3 true PL3528825T3 (pl) 2022-01-31

Family

ID=61054421

Family Applications (2)

Application Number Title Priority Date Filing Date
PL21178348.5T PL3912630T3 (pl) 2016-10-19 2017-10-19 Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych
PL17835861T PL3528825T3 (pl) 2016-10-19 2017-10-19 Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL21178348.5T PL3912630T3 (pl) 2016-10-19 2017-10-19 Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych

Country Status (11)

Country Link
US (1) US11541081B2 (pl)
EP (2) EP3528825B1 (pl)
JP (1) JP7235654B2 (pl)
KR (1) KR102584057B1 (pl)
CN (1) CN110352065A (pl)
CA (1) CA3040814A1 (pl)
DK (1) DK3528825T3 (pl)
ES (2) ES2894498T3 (pl)
MX (1) MX2019004611A (pl)
PL (2) PL3912630T3 (pl)
WO (1) WO2018073651A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110055320A (zh) * 2012-03-17 2019-07-26 加州大学评议会 痤疮的快速诊断和个体化治疗
WO2016172196A1 (en) 2015-04-20 2016-10-27 Pätzold Bernhard Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
PL3912630T3 (pl) * 2016-10-19 2024-04-15 S-Biomedic Nv Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych
US11926876B2 (en) * 2017-03-10 2024-03-12 Prodermiq, Inc. Customized skin care products and personal care products based on the analysis of skin flora
EP3806820B1 (de) * 2018-06-14 2026-06-03 Beiersdorf AG Kosmetische zubereitung gegen akne
ES2994459T3 (en) * 2018-11-16 2025-01-24 S Biomedic Nv Compositions for treating oxidative stress-associated skin diseases and skin ageing
CN114901246A (zh) * 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
US20230038623A1 (en) 2019-10-03 2023-02-09 Beiersdorf Ag Novel skin care composition
WO2021063528A1 (en) 2019-10-03 2021-04-08 S-Biomedic Novel skin care composition
MX2022004056A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
MX2022004050A (es) * 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
MX2022004048A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
BR112022006342A2 (pt) 2019-10-03 2022-06-28 S Biomedic Composição inovadora de cuidados com a pele
CN110846375B (zh) * 2019-10-23 2023-05-05 深圳艾尔生物科技有限公司 一种用于细菌电阻计数的培养基组合物、制备方法及其应用
US11197824B2 (en) * 2020-01-16 2021-12-14 David Changaris Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
CA3239122A1 (en) 2021-12-17 2023-06-22 S-Biomedic A freeze-dried composition and preparation thereof
EP4197523A1 (en) 2021-12-17 2023-06-21 DSM IP Assets B.V. A freeze-dried composition and preparation thereof
WO2023135186A1 (en) 2022-01-12 2023-07-20 S-Biomedic Nv Skin care composition and uses thereof
EP4778510A1 (en) 2025-01-15 2026-07-22 S-Biomedic NV Skin care composition and uses thereof

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69310339T2 (de) 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
US5650149A (en) 1993-12-15 1997-07-22 Kabushiki Kaisya Advance Cosmetic composition for proliferating indigenous bacteria on skin
US6743609B1 (en) 1997-12-23 2004-06-01 Arkion Life Sciences Llc Linoleate isomerase
US6821770B1 (en) 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6794537B1 (en) 2002-11-07 2004-09-21 Sami Labs Limited Manufacturing processes for Se-methyl-L-selenocysteine
WO2006138056A1 (en) 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
EP2184997A4 (en) 2007-07-31 2010-11-03 Univ New York DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES
BRPI0916690B1 (pt) 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
EP2378872A4 (en) 2008-12-18 2012-05-16 B Eugene Guthery TREATMENT PLAN FOR ACNE VULGARIS
US20100260695A1 (en) 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
ITPR20110035A1 (it) 2011-05-06 2012-11-07 Bormioli Rocco & Figlio Spa Capsula.
US9649346B2 (en) 2011-11-02 2017-05-16 Bios Llc Probiotic stick formulation for skin maintenance and methods of use
CN110055320A (zh) 2012-03-17 2019-07-26 加州大学评议会 痤疮的快速诊断和个体化治疗
KR102099503B1 (ko) 2013-06-05 2020-04-09 리바이오틱스, 인코퍼레이티드 미생물상 복원 요법(mrt) 조성물
US20150037285A1 (en) 2013-07-03 2015-02-05 New York University Methods for efficient transfer of viable and bioactive microbiota
US20150050245A1 (en) 2013-08-14 2015-02-19 Tntgamble, Inc. Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora
CN106456678A (zh) * 2014-04-15 2017-02-22 Ao生物医学有限责任公司 氨氧化型亚硝化单胞菌菌株d23
EP4299122A3 (en) 2014-05-07 2024-03-27 The Regents of The University of California Compositions and methods for treating skin and mucous membrane diseases
CN118979001A (zh) 2014-06-17 2024-11-19 皇冠实验室有限公司 经遗传修饰的细菌和用于细菌的遗传修饰的方法
WO2016172196A1 (en) * 2015-04-20 2016-10-27 Pätzold Bernhard Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
CN105168077A (zh) * 2015-08-14 2015-12-23 无限极（中国）有限公司 一种皮肤护理组合物及其应用、制备方法、产品
WO2017044835A1 (en) 2015-09-10 2017-03-16 Xycrobe Therapeutics, Inc. Genetically modified bacteria, compositions and methods of making and using
JP2019509263A (ja) * 2016-02-05 2019-04-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 皮膚の健康増進用組成物及び健康増進方法
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
ITUA20162141A1 (it) 2016-03-31 2017-10-01 Bormioli Pharma Spa Capsula di chiusura
EP3445448A4 (en) 2016-04-21 2020-03-18 Naked Biome, Inc. THERAPEUTIC AGENTS FOR SKIN CONDITIONS AND METHODS OF USE
EP3445844A4 (en) 2016-04-21 2019-11-13 Naked Biome, Inc. SYNTHETIC BACTERIA AND METHODS OF USE
EP3448398A4 (en) * 2016-04-21 2019-12-18 Naked Biome, Inc. COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
IT201600097495A1 (it) 2016-09-28 2018-03-28 Bormioli Pharma S R L Capsula con struttura di contenimento e rilascio di un prodotto
PL3912630T3 (pl) * 2016-10-19 2024-04-15 S-Biomedic Nv Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych
US11103443B2 (en) 2017-05-22 2021-08-31 Dermala Compositions and methods for preventing, slowing, and reversing skin aging
EP3806820B1 (de) 2018-06-14 2026-06-03 Beiersdorf AG Kosmetische zubereitung gegen akne
ES2994459T3 (en) 2018-11-16 2025-01-24 S Biomedic Nv Compositions for treating oxidative stress-associated skin diseases and skin ageing
MX2022004056A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
US20230038623A1 (en) 2019-10-03 2023-02-09 Beiersdorf Ag Novel skin care composition
WO2021063528A1 (en) 2019-10-03 2021-04-08 S-Biomedic Novel skin care composition
MX2022004048A (es) 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.
BR112022006342A2 (pt) 2019-10-03 2022-06-28 S Biomedic Composição inovadora de cuidados com a pele
CN114901246A (zh) 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
MX2022004050A (es) * 2019-10-03 2022-05-02 S Biomedic Composicion novedosa para el cuidado de la piel.

Also Published As

Publication number Publication date
EP3528825B1 (en) 2021-07-14
ES2967029T3 (es) 2024-04-25
EP3912630B1 (en) 2023-10-11
US20210187043A9 (en) 2021-06-24
DK3528825T3 (da) 2021-08-30
WO2018073651A1 (en) 2018-04-26
US11541081B2 (en) 2023-01-03
EP3528825A1 (en) 2019-08-28
EP3912630C0 (en) 2023-10-11
US20190314428A1 (en) 2019-10-17
JP2019535681A (ja) 2019-12-12
JP7235654B2 (ja) 2023-03-08
CN110352065A (zh) 2019-10-18
EP3912630A1 (en) 2021-11-24
CA3040814A1 (en) 2018-04-26
MX2019004611A (es) 2019-09-18
ES2894498T3 (es) 2022-02-14
KR20190084988A (ko) 2019-07-17
KR102584057B1 (ko) 2023-09-27
PL3912630T3 (pl) 2024-04-15

Similar Documents

Publication Publication Date Title
PL3912630T3 (pl) Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych
EP3268018A4 (en) Bacterial compositions and methods of use thereof
EP3285872A4 (en) METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS
IL256621A (en) Carrier-binder preparations and methods for their preparation and use
ZA201802063B (en) Personal cleansing compositions and methods of stabilizing the microbiome
EP3233048A4 (en) Compositions and methods for improving the appearance of the skin
EP3092001A4 (en) Immunomodulatory compositions and methods of use thereof
ZA202202259B (en) Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
EP3253403A4 (en) Methods and compositions for improved cognition
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3110891A4 (en) Low-voc compositions and methods of making and using the same
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
EP3113774A4 (en) Compositions of grapiprant and methods for using the same
EP3253396A4 (en) Probiotic compositions and methods of use
EP3137908A4 (en) Methods and compositions for diagnosis and treatment of meningitis
PT3503885T (pt) Composição farmacêutica e métodos de utilização
PL3454873T3 (pl) Kompozycja probiotyczna i jej zastosowania
IL261794A (en) Preparations and methods for using them
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
LT3226827T (lt) Aliuminio neturinčio antiperspiranto (dezodoranto) kompozicijos ir jų gavimo būdai
HK40001917A (en) Compositions and methods for promoting skin health
AU2016905369A0 (en) Methods and compositions for purification or isolation
AU2016905156A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
HUP1400338A2 (hu) Probiotikus baktériumok alkalmazása külsõ hallójárat gyulladás kezelésére, továbbá azokat tartalmazó készítmény
AU2016901339A0 (en) Compositions and methods of use